We can easily meet that objective, because we have drugs that are effective, free (or very cheap), that have low delivery costs, and that provide add-on benefits. Now is the time to rethink our public-health investments and messaging, and evaluate whether we are getting the best value for our donor dollars, or whether we should do much more to tackle diseases that we have so far largely ignored.
我们可以轻易地实现这样的目标，因为我们拥有免费（或低廉）的有效药物，施用的成本不高，而且还有附带的好处。现在是时候重新考虑我们的公共卫生投资和宣传，评价我们捐赠的善款是否发挥了最大的作用，思考我们是否应该加大对一直以来被我们忽视的疾病的力度。